Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence
New England Journal of Medicine · 2023
DOI: 10.1056/nejmc2304100 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, 2023. Verfasst von Vikram S Lyall und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dartmouth Hitchcock Medical Center, Lebanon, NH vikram.s.lyall@hitchcock.org. Hauptthemen laut MEDLINE: Hydrochlorothiazide, Kidney Calculi. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dartmouth Hitchcock Medical Center, Lebanon, NH vikram.s.lyall@hitchcock.org.
- University of Alabama at Birmingham, Birmingham, AL.
- Dartmouth Hitchcock Medical Center, Lebanon, NH.
Zitieren
APA
Lyall, V. S., Wood, K. D., & Pais, V. M. (2023). Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. New England Journal of Medicine. https://doi.org/10.1056/nejmc2304100
Vancouver
Lyall VS, Wood KD, Pais VM. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. New England Journal of Medicine. 2023. doi:10.1056/nejmc2304100
BibTeX
@article{Lyall2023,
author = {Lyall, Vikram S and Wood, Kyle D and Pais, Vernon M},
title = {Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence},
journal = {New England Journal of Medicine},
year = {2023},
doi = {10.1056/nejmc2304100}
}
EUVIMED